CompletedPhase 3

Optimum Misoprostol Dose Prior to Office Hysteroscopy

Egypt132 participantsStarted 2012-06

Plain-language summary

Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal route is the best, optimum dose not yet known.

Who can participate

Age range18 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female patient pre- or postmenopausal undergo office hysteroscopy. * Age: from 20 to 60. * BMI between 18 and 30. Exclusion Criteria: * PID or * Heavy uterine bleeding * Cervical malignancy. * Symptoms suggestive of endometriosis . * Any cervical abnormality such as pinhole cervix that would obviate passage of a catheter through the cervix.

What they're measuring

Pain score

Timeframe: 1year

Trial details

NCT IDNCT01612065

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-03

View on ClinicalTrials.gov More Infertility trials